Biotech
Foundation Medicine
Foundation Medicine raises $100M Series D at $1B valuation
$100M
Total Raised
Series D
Latest Round
2010
Founded
1000+
Employees
Cambridge, MA
1 min read
Quick Facts
Valuation
$1B
Latest Round Size
$100M
Latest Round Date
March 2015
Foundation Medicine: Series D Funding Round
Foundation Medicine has successfully raised $100M in Series D funding, reaching a valuation of $1B.
Company Overview
Genomic profiling for cancer treatment
Funding Details
The Series D round was led by Third Rock Ventures, with participation from Google Ventures.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2010
- Employees: 1000+
- Category: Biotech
Investment
Foundation Medicine plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Third Rock Ventures: Verified investor in Series D
- Google Ventures: Verified investor in Series D
Key Investors
Third Rock Ventures
Lead Investor
Verified investor in Series D
Google Ventures
Investor
Verified investor in Series D
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M